RESILIENCE GOVERNMENT SERVICES, INC.
SAN DIEGO, CA

Ology Bio has been highly successful in obtaining US Government contracts and grants (more than $500M to date) for the advanced development and manufacturing of drugs and biologics of importance to both healthcare and national security. Ology Bio works with the DoD, BARDA and NIAID to advance medical countermeasures to protect the American warfighter. We work with technology providers to obtain USG funding and to provide CDMO services to advance their products. Ology Bio has been highly successful in obtaining US Government contracts and grants (more than $500M to date) for the advanced development and manufacturing of drugs and biologics of importance to both healthcare and national security. Ology Bio works with the DoD, BARDA and NIAID to advance medical countermeasures to protect the American warfighter. We work with technology providers to obtain USG funding and to provide CDMO services to advance their products. We can screen production strains to select a cell line that will efficiently provide the best possible expression of your drug substance. We develop processes to take advantage of methods, such as high cell density fermentation, to increase product yield and manufacture the best quality product in the most efficient way possible. In creating a manufacturing process suitable for cGMP production, our process scientists take a modular, to develop optimal fermentation and product recovery processes, as well as downstream purification steps. The Process Development group works hand-in-hand with our Analytical Group to ensure the integrity of your molecule each step of the way. The company was founded in 1999 as an integrated biopharmaceutical company with a focus on development and manufacturing as well as having expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. From its early beginnings, the company’s growth was fueled through grants and contracts from both industry and several U.S. Government (USG) agencies (NIH, DoD, NCI, BARDA). Today, the company has grown to over 185 employees located in several offices across the U.S. On March 30, 2013, the Department of Defense (DoD) awarded the company and its team of partners and collaborators a contract to provide all of the core services necessary to establish a Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) facility dedicated to meeting the specific needs of the DoD. The 10-year, $400+ million contract had a base period goal for the construction of an 183,000-square-foot, state-of-the-art, BSL-3, single-use facility that the company now occupies and operates. Ology Bio recently developed and acquired proprietary platform technologies that are used in the production of biologic products including proteins, monoclonal antibodies, and vaccines. From process development, quality control testing, and cGMP manufacturing of bulk drug substances to development, scale-up, and production using our proprietary platform technologies, our goal is to manufacture only the highest quality biopharmaceutical products for our partners 183,000 SQFT, BSL-3, cGMP, ISO 9001… Our multi-purpose and multi-product biologics and vaccine facility is designated an “ How Can We Help? We’d love to help you develop your next medical breakthrough. Use the form below, or just email us directly How Can We Help? We’d love to help you develop your next medical breakthrough. Use the form below, or just email us directly